RELMADA THERAPEUTICS, INC. Annual Return On Assets in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Relmada Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2013 to 2023.
  • Relmada Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -112 %, a 30.5% decline year-over-year.
  • Relmada Therapeutics, Inc. annual Return On Assets for 2023 was -85.1 %, a 5.9% decline from 2022.
  • Relmada Therapeutics, Inc. annual Return On Assets for 2022 was -80.4 %, a 15.5% increase from 2021.
  • Relmada Therapeutics, Inc. annual Return On Assets for 2021 was -95.1 %, a 97.5% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -85.1 -4.74 -5.9% Jan 1, 2023 Dec 31, 2023
2022 -80.4 +14.7 +15.5% Jan 1, 2022 Dec 31, 2022
2021 -95.1 -46.9 -97.5% Jan 1, 2021 Dec 31, 2021
2020 -48.2 -4.82 -11.1% Jan 1, 2020 Dec 31, 2020
2019 -43.3 +136 +75.8% Jan 1, 2019 Dec 31, 2019
2018 -179 -60.1 -50.5% Jul 1, 2017 Jun 30, 2018
2017 -119 -99.1 -500% Jul 1, 2016 Jun 30, 2017
2016 -19.8 +53.9 +73.1% Jul 1, 2015 Jun 30, 2016
2015 -73.7 Jul 1, 2014 Jun 30, 2015
2013 -336 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.